P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

gan Kochhar, S, Excler, J, Fast, P
Cyhoeddwyd 2009

The mechanism of sunlight-mediated inactivation of Bacillus thuringiensis crystals.

gan Pusztai, M, Fast, P, Gringorten, L, Kaplan, H, Lessard, T, Carey, P R
Cyhoeddwyd 1991

Use of oligonucleotide probes to study the relatedness of delta-endotoxin genes among Bacillus thuringiensis subspecies and strains.

gan Prefontaine, G, Fast, P, Lau, P C, Hefford, M A, Hanna, Z, Brousseau, R
Cyhoeddwyd 1987

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda

gan Mukamuyango, J, Karita, E, Bayingana, R, Nyombayire, J, Ingabire, R, Allen, S, Tichacek, A, Fast, P, Price, M, Schmidt, C
Cyhoeddwyd 2012

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control

gan Kamali, A, Nsubuga, R N, Ruzagira, E, Bahemuka, U, Asiki, G, Price, M A, Newton, R, Kaleebu, P, Fast, P
Cyhoeddwyd yn Sex Transm Infect (2016)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

gan Fast P, Schmidt C, Tichacek A, Grabowski K, Bizimana J, Sebahungu F, Bayingana R, Kayitenkore K, Karita E, Hunter E, Allen S
Cyhoeddwyd 2009-10-01

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

gan Karita, E, Kayitenkore, K, Bayingana, R, Sebahungu, F, Bizimana, J, Grabowski, K, Tichacek, A, Schmidt, C, Fast, P, Hunter, E, Allen, S
Cyhoeddwyd 2009

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned

gan Bayingana, R, Nanvubya, A, Karita, E, Nyombayire, J, Ingabire, R, Chinyenze, K, Lehrman, J, Schimidt, C, Hannaman, D, Allen, S, Fast, P
Cyhoeddwyd 2012

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

gan Mpendo, J, Bayingana, R, Nanvubya, A, Karita, E, Ssetaala, A, Kiwanuka, N, Lehrman, J, Schmidt, C, Hannaman, D, Allen, S, Fast, P
Cyhoeddwyd 2012

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

gan Mutua, G, Omosa-Manyonyi, G, Park, H, Bergin, P, Laufer, D, Amornkul, PN, Lehrman, J, Fast, P, Gilmour, J, Anzala, O, Farah, B
Cyhoeddwyd 2012

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study

gan Lindegger, G, Quayle, M, Singh, S, Welsh, S, Mark, D, Wallace, M, Roux, S, Bekker, L, Mwananyanda, L, Kilembe, W, Chomba, E, Allen, S, Priddy, F, Fast, P
Cyhoeddwyd 2012

Vaccine responses to conserved regions of the HIV-1 proteome are associated with an increased capacity to inhibit multiple virus isolates ex vivo

gan Ashraf, A, Kopycinski, J, Cheeseman, H, Lala, F, Czyzewska-Khan, J, Spentzou, A, Gill, DK, Keefer, M, Excler, J, Fast, P, Hayes, P, Cox, JH, Gilmour, J
Cyhoeddwyd 2012

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules

gan Gorse, G. J., Schwartz, D. H., Graham, B. S., Matthews, T. J., Stablein, D. M., Frey, S. E., Belshe, R. B., Clements, M. L., Wright, P. F., Eibl, M., Fast, P. E.
Cyhoeddwyd 1994

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

gan Ngongo, BP, Priddy, F, Park, H, Bender, B, Fast, P, Anzala, O, Mutua, G, Ruzagira, E, Kamali, A, Karita, E, Mugo, P, Chomba, E, Bekker, L, Roux, S, Nanvubya, A, Mebrahtu, T
Cyhoeddwyd 2012

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis

gan Hassan, A.S., Hare, J., Kamini, G., Yindom, L.M., Kamali, A., Karita, E., Kilemba, W., Price, M.A., Borrow, P., Bjorkman, P., Albert, J., Kaleebu, P., Allan, S., Fast, P., Hunter, E., Gilmour, J., Ndung’u, T., Rowland-Jones, S., Sanders, E.J., Esbjornsson, J.
Cyhoeddwyd yn Virus Evol (2017)

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

gan Vasan, S, Hurley, A, Schlesinger, SJ, Hannaman, D, Gardiner, DF, Dugin, DP, Boente-Carrera, MM, Vittorino, RM, Caskey, M, Andersen, J, Huang, Y, Cox, J, Tarragona, T, Gill, DK, Cheeseman, H, Clark, L, Dally, L, Smith, C, Schmidt, C, Park, H, Sayeed, E, Gilmour, J, Fast, P, Bernard, R, Ho, DD
Cyhoeddwyd 2009

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

gan Agnandji, S.T., Huttner, A., Zinser, M.E., Njuguna, P., Dahlke, C., Fernandes, J.F., Yerly, S., Dayer, J.-A., Kraehling, V., Kasonta, R., Adegnika, A.A., Altfeld, M., Auderset, F., Bache, E.B., Biedenkopf, N., Borregaard, S., Brosnahan, J.S., Burrow, R., Combescure, C., Desmeules, J., Eickmann, M., Fehling, S.K., Finckh, A., Goncalves, A.R., Grobusch, M.P., Hooper, J., Jambrecina, A., Kabwende, A.L., Kaya, G., Kimani, D., Lell, B., Lemaître, B., Lohse, A.W., Massinga-Loembe, M., Matthey, A., Mordmüller, B., Nolting, A., Ogwang, C., Ramharter, M., Schmidt-Chanasit, J., Schmiedel, S., Silvera, P., Stahl, F.R., Staines, H.M., Strecker, T., Stubbe, H.C., Tsofa, B., Zaki, S., Fast, P., Moorthy, V., Kaiser, L., Krishna, S., Becker, S., Kieny, M.-P., Bejon, P., Kremsner, P.G., Addo, M.M., Siegrist, C.-A.
Cyhoeddwyd yn N Engl J Med (2015)